CIK: 0001056807 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 14, 2024
Total Value ($000): $3,418,343 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 21,751,284 | $1,096,700 | 32.1% | $6.29 | +645.5% | CLASS A ORD | 61559X104 |
| KYMR | KYMERA THERAPEUTICS INC | 5,161,801 | $244,308 | 7.1% | $32.15 | +37.4% | COM | 501575104 |
| RVMD | REVOLUTION MEDICINES INC | 3,478,612 | $157,755 | 4.6% | $25.19 | +72.8% | COM | 76155X100 |
| MIRM | MIRUM PHARMACEUTICALS INC | 3,075,907 | $119,960 | 3.5% | $27.38 | +45.7% | COM | 604749101 |
| TYRA | TYRA BIOSCIENCES INC | 4,661,194 | $109,585 | 3.2% | $16.23 | +29.4% | COM | 90240B106 |
| OLMA | OLEMA PHARMACEUTICALS INC | 9,135,893 | $109,083 | 3.2% | $37.66 | -66.1% | COM | 68062P106 |
| GPCR | STRUCTURE THERAPEUTICS INC | 2,238,986 | $98,269 | 2.9% | $34.21 | — | SPONSORED ADS | 86366E106 |
| CGEM | CULLINAN THERAPEUTICS INC | 5,750,683 | $96,266 | 2.8% | $20.31 | -12.6% | COM | 230031106 |
| XOMA | XOMA ROYALTY CORPORATION | 3,633,743 | $96,222 | 2.8% | $15.57 | +74.0% | COM NEW | 98419J206 |
| AXSM | AXSOME THERAPEUTICS INC | 1,046,000 | $94,004 | 2.7% | $75.19 | +16.1% | COM | 05464T104 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 1,850,167 | $83,258 | 2.4% | $17.69 | +128.4% | COM | 74366E102 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 7,382,642 | $79,806 | 2.3% | $20.48 | -19.0% | COM | 35104E100 |
| ACIU | AC IMMUNE SA | 19,522,436 | $73,795 | 2.2% | $4.52 | -22.8% | SHS | H00263105 |
| GHRS | GH RESEARCH PLC | 10,400,158 | $69,577 | 2.0% | $18.98 | -46.0% | ORDINARY SHARES | G3855L106 |
| KURA | KURA ONCOLOGY INC | 3,371,761 | $65,884 | 1.9% | $13.94 | +45.4% | COM | 50127T109 |
| — | THIRD HARMONIC BIO INC | 4,365,933 | $59,158 | 1.7% | $16.07 | — | COM | 88427A107 |
| IONS | IONIS PHARMACEUTICALS INC | 1,451,879 | $58,162 | 1.7% | $39.80 | +16.9% | COM | 462222100 |
| ZYME | ZYMEWORKS INC | 4,607,935 | $57,830 | 1.7% | $7.03 | +55.0% | COM | 98985Y108 |
| — | ESSA PHARMA INC | 8,748,629 | $53,017 | 1.6% | $3.65 | — | COM NEW | 29668H708 |
| AGIO | AGIOS PHARMACEUTICALS INC | 1,190,107 | $52,876 | 1.5% | $36.09 | +25.8% | COM | 00847X104 |
| CELC | CELCUITY INC | 3,466,000 | $51,678 | 1.5% | $16.73 | -1.5% | COM | 15102K100 |
| — | 89BIO INC | 6,811,631 | $50,406 | 1.5% | $10.69 | — | COM | 282559103 |
| FHTX | FOGHORN THERAPEUTICS INC | 5,302,000 | $49,362 | 1.4% | $5.96 | +21.6% | COM | 344174107 |
| GLPG | GALAPAGOS NV | 1,569,422 | $45,184 | 1.3% | $38.91 | — | SPON ADR | 36315X101 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,409,993 | $44,669 | 1.3% | $21.10 | +79.7% | COM | 45166A102 |
| ANNX | ANNEXON INC | 7,000,000 | $41,440 | 1.2% | $2.47 | +139.5% | COM | 03589W102 |
| CGON | CG ONCOLOGY INC | 994,596 | $37,526 | 1.1% | $39.48 | -11.2% | COM | 156944100 |
| — | REPARE THERAPEUTICS INC | 10,333,600 | $35,548 | 1.0% | $19.56 | — | COM | 760273102 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 1,521,948 | $25,264 | 0.7% | $9.95 | +73.9% | ORDINARY SHARES | N62509109 |
| XNCR | XENCOR INC | 850,000 | $17,094 | 0.5% | $18.77 | 0.0% | COM | 98401F105 |
| ELDN | ELEDON PHARMACEUTICALS INC | 6,293,282 | $15,670 | 0.5% | $4.95 | -45.9% | COM | 28617K101 |
| TCRX | TSCAN THERAPEUTICS INC | 2,989,474 | $14,888 | 0.4% | $2.68 | +125.2% | COM | 89854M101 |
| ENGN | ENGENE HOLDINGS INC | 2,251,037 | $14,857 | 0.4% | $10.40 | -28.5% | COM | 29286M105 |
| IMUX | IMMUNIC INC | 8,902,972 | $14,690 | 0.4% | $1.30 | +9.6% | COM | 4525EP101 |
| — | ALLAKOS INC | 16,552,417 | $10,812 | 0.3% | $3.39 | — | COM | 01671P100 |
| AVTX | AVALO THERAPEUTICS INC | 967,000 | $9,148 | 0.3% | $10.31 | 0.0% | COM NEW | 05338F306 |
| — | IKENA ONCOLOGY INC | 4,769,164 | $8,251 | 0.2% | $12.00 | — | COM | 45175G108 |
| — | CIDARA THERAPEUTICS INC | 703,065 | $7,558 | 0.2% | $11.33 | — | COM NEW | 171757206 |
| CTMX | CYTOMX THERAPEUTICS INC | 5,228,461 | $6,170 | 0.2% | $5.34 | -76.2% | COM | 23284F105 |
| — | VIGIL NEUROSCIENCE INC | 1,813,633 | $6,166 | 0.2% | $9.10 | — | COM | 92673K108 |
| VTGN | VISTAGEN THERAPEUTICS INC | 2,000,000 | $6,020 | 0.2% | $3.78 | -9.8% | COM | 92840H400 |
| VSTM | VERASTEM INC | 1,685,219 | $5,039 | 0.1% | $6.94 | -60.9% | COM NEW | 92337C203 |
| OVID | OVID THERAPEUTICS INC | 3,853,818 | $4,548 | 0.1% | $4.24 | -75.4% | COM | 690469101 |
| — | PIERIS PHARMACEUTICALS INC | 257,626 | $4,313 | 0.1% | $9.88 | — | COM NEW | 720795202 |
| — | VERVE THERAPEUTICS INC | 650,000 | $3,146 | 0.1% | $34.35 | — | COM | 92539P101 |
| SABS | SAB BIOTHERAPEUTICS INC | 917,826 | $2,478 | 0.1% | $5.51 | -49.7% | COM NEW | 78397T202 |
| MOLN | MOLECULAR PARTNERS AG | 443,221 | $2,136 | 0.1% | $19.71 | — | ADS | 60853G106 |
| — | ELEVATION ONCOLOGY INC | 2,966,836 | $1,780 | 0.1% | $8.04 | — | COM | 28623U101 |
| — | GLYCOMIMETICS INC | 9,544,262 | $1,613 | 0.0% | $4.18 | — | COM | 38000Q102 |
| IVA | INVENTIVA SA | 686,040 | $1,269 | 0.0% | $13.70 | — | ADS | 46124U107 |
| TENX | TENAX THERAPEUTICS INC | 339,549 | $1,175 | 0.0% | $3.62 | 0.0% | COM NEW | 88032L605 |
| ENGNW | ENGENE HOLDINGS INC | 945,402 | $804 | 0.0% | $0.85 | — | *W EXP 10/31/202 | 29286M113 |
| — | MOLECULAR TEMPLATES INC | 522,238 | $734 | 0.0% | $6.32 | — | COM NEW | 608550208 |
| — | NLS PHARMACEUTICS LTD | 143,676 | $728 | 0.0% | $5.07 | — | COM NEW | H57830137 |
| FBRX | FORTE BIOSCIENCES INC | 119,282 | $668 | 0.0% | $10.28 | 0.0% | COM NEW | 34962G208 |